ONO-7475

· Ono Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ONO-7475, covering 2024-05-16 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer [Phase 1]

See pricing